Channel
@DRDRMMM
On this record: Topic · Observations · Also posting the same content · Growth · Engagement · Posts · Citations · Cite this entry
1,053subscribers
-1 since we began measuring on 7 August 2026
Risers and fallers across the register · movement among entries of 1,000–3,162.
| Telegram ID | -1001120123789 |
|---|---|
| Type | Channel |
| Username | @DRDRMMM |
| Created | Between 1 May 2017 and 31 August 2019— estimated from Telegram’s id allocation, not measured. How this range is calculated. |
| First recorded | 8 August 2026 |
| Last confirmed live | 10 August 2026 |
| Measurements held | 3 |
| Confirmed unchanged | 1 time, most recently 10 August 2026 |
| On Telegram | t.me/DRDRMMM |
Other / unclassifiable — a classification, not a measurement. An on-box language model (Qwen3.6-35B-A3B-UD-Q6_K_XL, prompt version 1) read this channel’s own recent posts on 11 August 2026 and assigned it the closest of 31 fixed categories, at 49% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and why it has no browse page of its own yet.
These are measurements, not verdicts. Each one below states something we counted, alongside the evidence it was counted from, so you can check it rather than take it. None of them is graded: every observation this register holds is recorded at severity 0, because the precision of the detectors behind them has not been measured yet, and a rating we cannot support is worse than none. Read each as a fact about the data, not as a judgement about the channel. How we measure.
Posts published here appear word for word on 3 other registered channels. The matching is on the text itself, not on Telegram’s forward marker, so it finds a copy whether or not it was labelled as one.
| Posted first | Then | Overlap | Gap |
|---|---|---|---|
| @GOODPP/40523 Dec 2025, 17:50 UTC | @DRDRMMM/2102 · this entry23 Dec 2025, 17:53 UTC | 1.00 | 4 minutes |
| @CLINICPHARMA/88923 Dec 2025, 17:50 UTC | @DRDRMMM/2102 · this entry23 Dec 2025, 17:53 UTC | 1.00 | 3 minutes |
| @INDPHARMA/94823 Dec 2025, 17:46 UTC | @DRDRMMM/2102 · this entry23 Dec 2025, 17:53 UTC | 1.00 | 7 minutes |
| Channel | Matching posts | Text overlap | Typical gap | Published first |
|---|---|---|---|---|
| @GOODPP | 5 (5/5 hand-verifiable sample passed) | 1.00 | 2 minutes | this entry (3–2) |
| @CLINICPHARMA | 5 (5/5 hand-verifiable sample passed) | 1.00 | 3 minutes | this entry (3–2) |
| @INDPHARMA | 5 (5/5 hand-verifiable sample passed) | 1.00 | 3 minutes | this entry (3–2) |
Text overlap is the Jaccard coefficient over the set of distinct three-word phrases in the two bodies: 1.00 is identical wording, and the threshold for counting a pair at all is 0.70. Candidates are generated by simhash LSH (4 x 16-bit bands, exact Hamming <= 3) verified against the bodies with Jaccard over the SET of distinct 3-word shingles. Published first counts which side of each matching pair carries the earlier timestamp — in this corpus, which is the limitation directly below.
What this cannot establish
MEASURED, DOMINANT ERROR SOURCE: a post ingested before 2026-08-06 may have carried a forward header that was not recorded. A 45-pair hand-check against live t.me pages found 14 (31%) where the live page shows a forward header naming the other channel and the database has none, plus 4 more (9%) naming a third party. The text match itself was wrong 0 times out of 45. Read attribution_capture.items_in_trusted_window before treating the unattributed count as a claim.
Telegram lets a channel forward a post with a header naming the source, and we only began reliably recording that header on 2026-08-06. None of the 3 matches recorded here fall after that date, so for this entry we cannot say whether any of them carried a credit. The duplication is measured; the absence of attribution is not.
“Published first” means first in this corpus. We hold 20 comparable posts for this entry, running 14 March 2023 to 27 December 2025. A channel we have read one page deep will look younger than a neighbour we have read in full, and the order would flip with no change in the underlying facts.
The detector’s own notes on this observation, as it recorded them. Names in this_style are fields of the underlying evidence record, which the plain-English paragraphs above read out for this entry.
Across the whole group of 4, the earliest publisher we hold is @DRDRMMM — which is this entry. That is a statement about our reading window, not a claim of authorship.
Recorded under the key clone_mutual, last confirmed 8 August 2026. An observation that a later pass no longer finds is cleared, and a cleared observation is removed from this page rather than being shown struck through — we do not keep publishing a claim we have withdrawn. Dispute an observation.
This channel’s posts match, word for word or near enough, posts on 3 other registered channels, found by comparing text fingerprints across every channel on the register. That matching has been checked by hand against the live Telegram pages and found reliable — 0 wrong of 45 pairs re-read.
Which channel, if either, published first is deliberately not shown. The same hand-check found that reading wrong 18 of 45 times — 60%, no better than a coin flip — because it depends on how deep our own crawl happened to reach into each channel’s history, not on when the content was actually first posted. This list is ordered by subscriber count, the same as every other listing on this site, never by which channel we think came first. Word-for-word matching has several ordinary explanations besides copying — a channel mirroring itself, an unattributed repost, or two channels independently repeating the same wire story — and this measurement cannot tell those apart. How this is measured.
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 10 Aug 2026, 23:02 | 1,053 | -1 |
| 8 Aug 2026, 00:19 | 1,054 | no change |
| 7 Aug 2026, 20:57 | 1,054 | first reading |
20 posts held, back to 14 March 2023 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 pageof Telegram’s post history, 20 posts per page.
Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 20 posts for this entry, the most recent from 27 December 2025. An engagement rate over an empty window would be a number about nothing.
https://www.facebook.com/100067022166413/posts/pfbid0HAPHaDatk8PWT6pwXt5Y1RqvcxivNxLHscezZRur5icffcSJtf3YSHy753msxEkol/?app=fbl أبحاث علمية لفريق بحثي من جامعة صنعاء تظهر في قائمة موقع جوجل باتنتس لبراءات الاختراع المرصد نيوز https://almrsadnews.net/ar/?p=56224 أظهر موقع جوجل باتنتس ( Google Patents) الخاص بتسجيل بيانات الاختراع، أبحاث علمية لفريق أكاديمي من جامعة صنعاء تتعلق بتطوير وصناعة الدواء وأنظمة توصيل ال…
⬅️بيانات براءات اختراع جوجل رئيس فريق البحث العلمي البروفيسور / محمود مهيوب البريهي قسم الصيدلانيات والصيدلة الصناعية كلية الصيدلة جامعة صنعاء اليمن. ➡️Google Patents Prof Dr. Mahmoud Mahyoob Alburyhi Department of Pharmaceutics and Industrial Pharmacy Faculty of Pharmacy Sana'a University Yemen. https://patents.google.com/scholar/3668419596722871974 https://t.me/ppdprogram/6322
🖌أبحاث تطوير وصناعة الدواء بيانات براءات اختراع جوجل Google Patents http://patents.google.com https://patents.google.com/scholar/3668419596722871974 🖌رئيس فريق البحث العلمي البروفيسور/ محمود مهيوب البريهي استاذ الصيدلانيات والصيدلة الصناعية كلية الصيدلة جامعة صنعاء ⬅️ أبحاث صناعة الدواء بمراحله المختلفة من مصادره الطبيعية و الصناعية في بيانات براءات اختراع جوجل ⬅️إنجاز و إنتاج الدواء اساسه البحث العلمي و حصاد.عشر…
🇵🇸اليوم العالمي للصيادلة 🇵🇸 25سبتمبر 2024 World Pharmacists Day 👈بمناسبة اليوم العالمي للصيادلة 👈تحت شعار (الصيادلة يلبون احتياجات الصحه العالمية ) FIP Pharmacists: Meeting Global Health Needs. 👈بهذه المناسبة صيادلة اليمن يطالبون اتحاد الصيادلة العرب واتحاد الصيادلة العالمي FIP بتجسيد شعار تلبية احتياجات الصحه العالمية تجسيد حقيقا وليس شكليا وذلك من خلال المطالبة والمتابعة ل الجهات الدولية المعنية بذلك في توفير ال…
5⃣Pharm Prof Note: Prof/Dr Mahmoud Mahyoob Alburyhi حركية الدواء و ديناميكية الدواء حركية الدواء هي تتضمن كل أسس حركية الدواء من معدل امتصاص الدواء و تركيز الدواء في البلازما و حجم توزيع الدواء في الدم والأنسجة و معدل اخراج وتصفية الدواء من الدم إلى خارج الجسم ونصف عمر الدواء في الدم والمساحة المحددة لعلاقة التركيز بالزمن لبقاء الدواء أو توافر الدواء في الدم و مكان الفعالية فحركية الدواء من المفاهيم المهمة في معر…
➡️RizaFilm (rizatriptan) Oral Film Date of Approval: April 14, 2023 Company: IntelGenx Corp. Treatment for: Migraine RizaFilm (rizatriptan) is a serotonin (5-HT) 1B/1D receptor agonist (triptan) oral film formulation for the acute treatment of migraine. https://t.me/DRDRMMM/2097 https://t.me/ppdprogram
➡️Omisirge (omidubicel-onlv) Suspension for Infusion Date of Approval: April 17, 2023 Company: Gamida Cell Ltd. Treatment for: Stem Cell Therapy Omisirge (omidubicel-onlv) is a nicotinamide (NAM) modified allogeneic hematopoietic progenitor cell therapy for use in patients with hematologic malignancies to reduce risk of infection following stem cell transplantation. https://t.me/ppdprogram
➡️RizaFilm (rizatriptan) Oral Film Date of Approval: April 14, 2023 Company: IntelGenx Corp. Treatment for: Migraine RizaFilm (rizatriptan) is a serotonin (5-HT) 1B/1D receptor agonist (triptan) oral film formulation for the acute treatment of migraine. https://t.me/ppdprogram
➡️Joenja (leniolisib) Tablets Date of Approval: March 24, 2023 Company: Pharming Group N.V. Treatment for: Activated Phosphoinositide 3-Kinase Delta Syndrome Joenja (leniolisib) is a kinase inhibitor indicated for the treatment of activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in adult and pediatric patients 12 years of age and older. https://t.me/ppdprogram
➡️Rezzayo (rezafungin) Powder for Injection Date of Approval: March 22, 2023 Company: Cidara Therapeutics, Inc. Treatment for: Candidemia, Systemic Candidiasis Rezzayo (rezafungin) is an echinocandin antifungal used for the treatment of candidemia and invasive candidiasis. https://t.me/ppdprogram
➡️Zynyz (retifanlimab-dlwr) Injection Date of Approval: March 22, 2023 Company: Incyte Treatment for: Merkel Cell Carcinoma Zynyz (retifanlimab-dlwr) is a programmed death receptor-1 (PD-1)-blocking antibody for the treatment of Merkel cell carcinoma. https://t.me/ppdprogram
➡️Daybue (trofinetide) Oral Solution Date of Approval: March 10, 2023 Company: Acadia Pharmaceuticals Inc. Treatment for: Rett Syndrome Daybue (trofinetide) is a synthetic analog of the amino‐terminal tripeptide of IGF-1 for the treatment of Rett syndrome. https://t.me/ppdprogram
Showing the 12 most recent of 20 posts we hold for @DRDRMMM. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
Citation-graph rank — 1,143,545 of 1,151,006entries in the measured graph. A weighted position computed from the forward and mention edges below — republished posts weigh more than named mentions — and recomputed periodically, over the whole graph. Published only as this ordinal position, never as a score: a position is a fact, and a score printed beside one channel’s name would read as a verdict this register does not make. The two counts beneath stay separate for the same reason mentions are never summed with forwards anywhere else on this page — a named-by count costs nothing to manufacture. The top 100 by this measure, or how it is computed.
Republishes
Channels on the register whose posts this channel has forwarded.
Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.
Named by 1 registered channel — every channel on the register whose own posts have named this one, by its current username or any other username it currently holds, merged from two separately captured readings of the same fact so a namer caught by only one of them is not missed and a namer both caught is not counted twice. A username this channel has since dropped is not matched — that handle may belong to someone else now, and crediting today’s namer to yesterday’s owner would misattribute it.
Named by
Channels on the register whose posts name this channel's handle.
Names
Channels on the register whose handles appear in this channel's posts.
A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 10 August 2026 — this entry's latest reading, not the date you are reading this.
“PPDPROGRAM-DRUG MARKETING” (@DRDRMMM), 1,053 subscribers as measured 10 August 2026. Telegram Register, tgregister.com/channel/DRDRMMM.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.